MedTrace Logo

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

NCT04330716 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 269

Last updated 2024-01-19

No results posted yet for this study

Summary

This study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.

Conditions

Interventions

BEHAVIORAL

Standard Genetic Counseling

Standard of care genetic counseling

BEHAVIORAL

Educational Video

Video tutorial about genetic testing

Sponsors & Collaborators

Principal Investigators

  • Huma Rana, MD · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04330716 on ClinicalTrials.gov